CLINICAL STUDIES ON CEFETAMET PIVOXIL

We evaluated the clinical efficacy and safety of cefetamet pivoxil (CEMT-PI), a new oral cephalosporin antibiotic, at a dose of 250-500 mg twice a day for 3-12 days in 13 patients with respiratory tract infections. The overall clinical efficacy was 83.3%(10/12). Eruption in one and slight increase o...

Full description

Saved in:
Bibliographic Details
Published inCHEMOTHERAPY Vol. 38; no. Supplement1; pp. 347 - 349
Main Authors TAKEBE, KAZUO, MASUDA, MITSUO, MURAKAMI, SEIICHI, SAGARA, MORIO, OKAMOTO, KATSUHIRO, TAMURA, TOYOKAZU, ENDO, KATSUMI, SATO, TATSURO, KUDO, KENJI, IMAMURA, KENICHI
Format Journal Article
LanguageEnglish
Japanese
Published Japanese Society of Chemotherapy 1990
Subjects
Cefetamet pivoxil
prodrug
Online AccessGet full text

Cover

More Information
Summary:We evaluated the clinical efficacy and safety of cefetamet pivoxil (CEMT-PI), a new oral cephalosporin antibiotic, at a dose of 250-500 mg twice a day for 3-12 days in 13 patients with respiratory tract infections. The overall clinical efficacy was 83.3%(10/12). Eruption in one and slight increase of GPT in two cases were observed.
ISSN:0009-3165
1884-5894
DOI:10.11250/chemotherapy1953.38.Supplement1_347